
AvantGen
San Diego, CA, United States avantgen.com From their website, Nov 2026
Work here? Claim this listing
About
AvantGen develops and optimizes antibody drugs for pharmaceutical and biotechnology partners. It also develops rabbit monoclonal antibodies and NK cell engager technology for therapeutic, diagnostic, and research applications.
Services
Antibody discovery
Generates antibodies for therapeutic, diagnostic, and research tool applications using yeast display and related screening methods.
Antibody optimization
Improves lead antibodies through affinity maturation, specificity optimization, species cross-reactivity, pH dependency, and liability removal.
Affinity maturation
Uses focused libraries and rapid screening to improve antibody affinity, often achieving 10- to 100-fold improvement.
Rabbit monoclonal antibody development
Generates rabbit monoclonal antibodies for nonhuman reagent or diagnostic uses.
NK cell engager development
Develops bi-specific NK cell engager antibody candidates targeting CD16a for cancer applications.
Antibody licensing
Offers fully human CD16a antibodies available for license.
- Turnaround
- Within weeks to months
Capabilities
- Assays and studies
- Antibodies
- Flow cytometry
- CHO
- HEK293
- Yeast display
- MACS
- FACS
- Flow cytometry-based screening
- Scale and capacity
- > 10^9 clones per focused library
- More than 100 billion antibody clones
- > 500 individuals deep-sequenced
- Therapeutic areas
- Cancer
- Immuno-oncology
Instruments and platforms
- MACS
- FACS
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- Peptide
- Species and models
- Saccharomyces cerevisiae
- HEK293 cells
- CHO cells
- Rabbit
Details
- Type
- CRDMO
- Based in
- San Diego, CA, United States
- Serves
- Worldwide